Nasdaq
ANTX
AN2 Therapeutics, Inc.
- Health Care
- Listed 2022
- 1 day
- +4.1%
- 1 month
- +41.4%
- 1 year
- +466%
$6.08 · Mkt cap $219M
At the 6 Aug 2026 close
Nasdaq
AN2 Therapeutics, Inc.
$6.08 · Mkt cap $219M
At the 6 Aug 2026 close
AN2 Therapeutics, Inc. trades under the ticker ANTX on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2022. Its market capitalisation is $219M. The last closing price was $6.08, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +466%, and +41.4% over the past month. Returns are price returns and exclude dividends.
This page exists because ANTX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.